Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Racine-Samson, L.
Right arrow Articles by Bissell, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Racine-Samson, L.
Right arrow Articles by Bissell, D. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 272, Number 49, Issue of December 5, 1997 pp. 30911-30917

The Role of alpha 1beta 1 Integrin in Wound Contraction
A QUANTITATIVE ANALYSIS OF LIVER MYOFIBROBLASTS IN VIVO AND IN PRIMARY CULTURE*

(Received for publication, May 13, 1997, and in revised form, September 10, 1997)

Lorraine Racine-Samson , Don C. Rockey and D. Montgomery Bissell Dagger

From the Liver Center Laboratory, San Francisco General Hospital, and the Department of Medicine, University of California, San Francisco, California 94110

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

An unresolved question in wound contraction concerns the identity of integrins mediating the attachment of tissue myofibroblasts to matrix in the injury site. Previous studies with cell lines have focussed on alpha 1beta 1 and alpha 2beta 1, the principal collagen-binding integrins, but have yielded conflicting data. We have examined this issue in wound healing in the liver, isolating the myofibroblast population (activated stellate cells) and quantitating expression of the alpha 1 and alpha 2 integrin subunits during the in vivo injury. Normal stellate cells displayed alpha 1 but no detectable alpha 2. During injury, alpha 1 expression was maintained; alpha 2 became detectable at the mRNA level but at all times was <8% of alpha 1 mRNA. Contraction of collagen lattices, studied with 24-h cultured cells and initiated by endothelin 1, was blocked 70% by anti-alpha 1 and 30% by anti-alpha 2 (both significant, p < 0.05). The inhibition by anti-alpha 2, which was unexpected, was attributable to culture-induced change in integrin expression; both the mRNA and protein for alpha 2 increased strikingly within 24 h of plating stellate cells on a collagen gel. We conclude that alpha 1beta 1 is the sole integrin utilized by contracting myofibroblasts in vivo. Although alpha 2beta 1 is capable of mediating contraction, its expression by myofibroblasts occurs largely, if not exclusively, in response to culture.


INTRODUCTION

Wound repair is a multi-step process in which contraction is an important element (1). In its initial phase, mesenchymal cells are drawn to the injury site, where they deposit a collagen-rich extracellular matrix (ECM).1 The ECM undergoes organization, with alignment of collagen fibrils. Myofibroblasts attach via matrix-binding surface receptors, which provide points of traction as cells shorten. The contractile action compacts the ECM lattice, promoting wound closure and restoring tissue integrity. Although this process is vital to host defense, it has a negative side. In epithelial tissues, repetitive injury leads to multiple cycles of wound repair with extensive deposition of ECM. Contraction in this setting may distort and disrupt tissue structure with undesirable consequences. For example, strips of cirrhotic liver are contractile (2), a property that may contribute to the portal hypertension that accompanies chronic liver disease.

For these reasons the molecular basis of contraction is under study. An important goal is characterizing the receptors that mediate the binding of myofibroblasts to ECM, as these are potential targets for therapeutic modulation of contraction. Given the importance of an organized collagen matrix to the contraction process, the "classical" collagen-binding receptors, alpha 1beta 1 and alpha 2beta 1 integrins, have come under particular scrutiny. Several investigations have taken advantage of the fact that cell lines with myofibroblast-like characteristics express one or both of these integrins (3-7). The conclusions have varied. A persuasive study with skin fibroblasts found that alpha 2beta 1 was essential and sufficient for contraction (7). In contrast, a recent report described a smooth muscle cell line that expresses alpha 1beta 1 only and is fully contractile; the same study found alpha 2beta 1 is not detectable by immunohistochemistry during vascular wound healing (4), raising questions about the in vivo relevance of alpha 2 expression in culture.

The present studies address the role of these integrins in vivo, in liver undergoing wound repair. Two models of liver injury have been used: total ligation of the bile duct and administration of dimethylnitrosamine. Both procedures reproducibly induce wound repair as evidenced by the appearance in the liver of myofibroblasts and fibrogenesis. The myofibroblast population in liver derives largely from stellate cells, which are liver pericytes (also known as Ito cells, fat-storing cells, or lipocytes) (8-10). In injury, stellate cells undergo a transition to myofibroblasts that is well-documented and has been termed activation (10). The singular advantage of the liver model for studies of wound repair is the availability of methods for preparing mass isolates of stellate cells. By analysis of isolates at various time points during the evolution of the injury, direct information on gene expression and function is obtained, representing a profile of in vivo integrin expression. Amplification of cells in culture, which routinely results in phenotypic change (10, 11), is avoided. The isolated cells are suitable also for direct in vitro assessment of their ECM binding activity and contractility.


EXPERIMENTAL PROCEDURES

Antibodies

Monoclonal blocking antibodies against rat alpha 1 (clone Ha31/8), alpha 2 (clone Ha1/29), beta 1 (clone Ha2/11), and murine alpha 1 (clone 3A3) integrin subunits were gifts from V. Koteliansky (Biogen Inc., Boston, MA) (12-14); clone 3A3 cross-reacts with the rat protein (4). MA2 polyclonal antibody against the cytoplasmic domain of murine alpha 2 integrin subunit was a gift from S. A. Santoro (St. Louis, MO) (15, 16). Polyclonal antibodies against the cytoplasmic domains of human integrins alpha 1 and alpha 2 subunits were gifts of G. Tarone (Torino, Italy). Monoclonal antibody against murine alpha v integrin subunit was obtained from Pharmingen (San Diego, CA).

cDNA Probes

The probe for alpha 1 integrin subunit was a 479-base pair cDNA (nucleotides 1871-2350) subcloned into pGEM4Z (Promega, Madison, WI) from a full-length cDNA provided by M. J. Ignatius (Berkeley, CA) (17). The probe for the alpha 2 integrin subunit was an 843-base pair cDNA (nucleotides 1456-2299) subclone in pBluescript II SK- kindly provided by S. A. Santoro (St. Louis, MO) (15).

Animal Models of Wound Repair

Hepatic injury was induced in male Sprague-Dawley rats (500-600 g) by ligation of the biliary duct. Bile duct ligation is well characterized with respect to the time course and extent of fibrogenesis (18, 19). Sham-operated animals underwent laparotomy and bile duct manipulation without ligation. Animals were maintained postoperatively on food and water ad libitum. In some studies, hepatic fibrosis was induced by intraperitoneal injection of dimethylnitrosamine in a dose of 1 µl (diluted 1:100 in 0.15 M NaCl)/100 g body weight given on the first 3 days of each week (20).

Stellate Cell Isolation and Culture

Stellate cells were isolated as described (21) by liver perfusion with Pronase (Boehringer Mannheim) and collagenase (Crescent Serva, Hauppause, NY) followed by ultracentrifugation on a discontinuous gradient of Accudenz® (8.2 and 15.6% w/v) (Accurate Chemicals, Westbury, NY). The top interface contained stellate cells, which were collected and washed twice in culture medium to remove debris. Stellate cells were identified by their intrinsic vitamin A autofluorescence (22) and by staining for the intermediate filament, desmin (9). Their purity was >95%. They were used fresh or plated in a modified medium 199 (23) containing 20% serum (10% horse, 10% calf; Life Technologies, Inc.).

RNase Protection Assay

Total RNA was extracted from stellate cells using Tri Reagent® (Molecular Research Center Inc., Cincinnati, OH) (24). Sample quality was assessed by agarose/formaldehyde gel electrophoresis. Radiolabeled antisense RNA probes were synthetized with the appropriate RNA polymerase (Promega) in the presence of [alpha -32P]CTP (>800 Ci/mmol; Amersham Corp.). Hybridization was performed in solution as described previously using equivalent amounts of RNA as determined by A260 readings of the extracts (21). Samples for a given experiment were run as a group, using the same preparation of probe(s) and gel analysis. Unhybridized RNA was digested with ribonuclease T2 (19). Intact hybrids were precipitated, denatured by boiling for 3 min in electrophoresis buffer, and separated by electrophoresis in a 5% polyacrylamide/urea gel. After drying, gels were applied to X-OMAT AR-5 film (Eastman Kodak, Rochester, NY). Scanning densitometry (Hoefer Scientific Instruments, San Francisco, CA) was used to quantitate the autoradiographic signals. RNA samples were also hybridized with a cDNA encoding 585 base pairs of the ribosomal protein S14 (25) as an internal control for the amount of mRNA present in an individual assay. S14 mRNA varies minimally after bile duct ligation (21). Densitometric data were normalized to S14 expression.

Flow Cytometry

Isolated cells were washed with PBS containing Ca2+ and Mg2+, and 200,000-500,000 cells were incubated in a blocking solution consisting of 10% goat serum in PBS for 15 min at room temperature. The primary antibody (clone Ha31/8 for alpha 1, clone Ha1/29 for alpha 2, and clone Ha2/11 for beta 1) was added to the cell sample and incubated for 25 min on ice. After washing with PBS, the cells were resuspended in phycoerythrin-conjugated anti-hamster IgG diluted in PBS (10 µg/106 cells) (Caltag, South San Francisco, CA), incubated for 20 min on ice in the dark, and then washed. The cells were analyzed for fluorescence on a FACStarPLUS Flow Cytometer (Becton Dickinson, San Jose, CA). For control samples, the primary antibody was replaced by non-immune IgG.

Immunohistochemistry on Liver Sections

The liver was perfused under low pressure in situ with PBS via the portal vein until free of blood and then removed and cut into small pieces, which were snap-frozen in isopentane prechilled in liquid nitrogen and stored at -80 °C. Immunohistology was performed on 8-µm thick cryostat sections fixed for 10 min in -20 °C acetone (15, 16). Sections were incubated 15-30 min in a blocking solution containing 1% fish gelatin (Sigma) in PBS and then incubated with either 3A3 anti-alpha 1 monoclonal antibody (1:500 dilution in blocking solution) (14) or with MA2 anti-alpha 2 polyclonal antibody (1:200 dilution) (15, 16). A biotinylated sheep anti-mouse IgG (1:200) (Amersham Corp.) or a biotinylated goat anti-rabbit IgG (1:200) (Vector Laboratories, Burlingame, CA) was added. After further washes, the sections were exposed to streptavidin-linked Texas Red (Amersham Corp.) (1:1,000) for 30 min, washed with PBS, and mounted in glycerol for fluorescence microscopy (Dako Corp., Carpinteria, CA). For negative controls, the primary antibody was omitted. Results were recorded with a Nikon Microphot-FX fluorescence microscope and Ilford HP5-plus (ASA 400) film.

Adhesion Assay

Cell attachment to collagen was performed as described (26). Briefly, untreated polystyrene 96-well flat-bottom microtiter plates (Lindro®/Titertek®, Flow Laboratories, McLean, VA) were coated with collagen type I or IV (10 µg/ml in PBS) (Sigma) or with 1% bovine serum albumin (Sigma) in PBS. Plates were washed with PBS and then blocked with 1% bovine serum albumin for 1 h. Cells were plated at a density of 100,000 cells/well in 200 µl of serum-free medium. For blocking experiments, they were preincubated with antibodies for 15 min at 4 °C before plating. After a 2-h incubation at 37 °C in a humidified 5% CO2 incubator, non-adherent cells were removed by three washes with PBS. The attached cells were fixed and stained with a solution containing 3% formaldehyde, 10% methanol, and 0.5% crystal violet for 1 h. After washing with PBS to eliminate excess dye, the wells were drained, and the absorbance at 595 nm was measured in a microplate reader (Bio-Rad). Values were corrected for background defined as adhesion to bovine serum albumin alone. Each assay was performed in triplicate.

Collagen Gel Contraction Assay

Contraction of stellate cells on collagen lattices was examined in 24-well flat-bottom tissue culture plates (Corning Glass Works, Corning, NY) as described previously (27). Briefly, culture vessels were preincubated with PBS containing 1% bovine serum albumin (Sigma) (500 µl per well) for at least 1 h at 37 °C and then washed twice with PBS and air dried. The gel mixture consisted of 8 parts Vitrogen (Celltrix Corp., Santa Clara, CA), 1 part (10 ×) minimal essential medium (Life Technologies, Inc.), and 1 part 0.2 M HEPES, pH 9.0, which resulted in a final collagen concentration of 2.4 mg/ml. It was prepared at 4 °C, added to the culture vessel, and incubated for 1 h at 37 °C to allow gelation. Stellate cells isolated from animals 6 days after bile duct ligation were plated on top of the gels. After cell attachment for 24 h, serum-free conditions were introduced and endothelin-1 (10-8 M, Peninsula Laboratories, Belmont, CA) was added to elicit contraction (27). Contraction was monitored as the change in lattice area over time. For integrin-blocking experiments, the appropriate antibodies (clones Ha31/8 for alpha 1, Ha1/29 for alpha 2 and Ha2/11 for beta 1) were added at plating. The antibody concentration was one that produced 95-100% of maximal inhibition, as determined in preliminary experiments. For anti-alpha 1, this was 217 µg/ml; for anti-alpha 2 it was 223 µg/ml, and for anti-beta 1 it was 235 µg/ml (all as purified IgG).

Metabolic Labeling and Immunoprecipitation

Stellate cells were metabolically labeled with [35S]methionine (5 mCi/100-mm plate; ICN, Irvine, CA) overnight in medium without methionine and cysteine. Cellular proteins were solubilized in immunoprecipitation buffer (100 mM Tris/HCl pH 7.4, 150 mM NaCl, 1 mM CaCl2, 0.1% SDS, 1% Triton X-100, 0.1% Nodinet P-40, 2 mM phenylmethylsulfonyl fluoride, 20 µg of aprotinin, 20 µg of leupeptin) for 30 min at 4 °C. The cell lysate was centrifuged 10 min at 10,000 × g, and the supernatant was precleared by incubation with protein A-Sepharose CL-4B beads (1:1, v/v, slurry in immunoprecipitation buffer; Pharmacia Biotech Inc.) for 45 min at 4 °C. Incubation with appropriate monoclonal antibody (clone Ha31/8 for alpha 1, clone Ha1/29 for alpha 2, and clone Ha2/11 for beta 1) was carried out overnight at 4 °C. Rabbit anti-hamster IgG (Pierce) was added 1 h before the end of the incubation, followed by addition of protein A-Sepharose beads. After a 45-min incubation, the beads with attached immune complexes were washed five times with immunoprecipitation buffer and then eluted by boiling for 5 min in 2 × Laemmli loading buffer and resolved in an 8% SDS-polyacrylamide gel. Dried gels were exposed to X-OMAT AR-5 film (Kodak).

Confocal Microscopy

For studies of cellular localization of alpha 1 and alpha 2, double labeling experiments were performed on stellate cells after 3 days in primary culture. Cells were fixed with 1.5% paraformaldehyde, 0.1% Triton X-100 for 10 min and then immunostained as described above (see "Immunohistochemistry on Liver Sections"). For evaluating co-localization of alpha 1 or alpha 2 and the actin cytoskeleton, double labeling using anti-talin antibody (1:100) (Amersham Corp.) was performed. Staining was analyzed with a confocal microscope (Meridian ACAS 570, Ohemos, MI). Generated images were corrected for compensation and threshold.

Statistical Analysis

Values are expressed as mean ± S.E. Statistics were performed with one-way analysis of variance with multiple comparisons. Statistical significance was assigned at probability value less than 0.05.


RESULTS

Expression of alpha 1 and alpha 2 Integrin mRNA by Stellate Cells in Vivo

The expression of alpha 1 and alpha 2 mRNA was examined in freshly isolated stellate cells and at various time points after bile duct ligation or dimethylnitrosamine treatment. In stellate cells from normal liver, alpha 1 mRNA was readily detected (Fig. 1, A and B), and after bile duct ligation, it remained essentially constant over the 6-day period of observation (Fig. 1, A and C). In contrast, alpha 2 mRNA was undetectable in normal stellate cells (Fig. 1, A and B). Although measurable after bile duct ligation (Fig. 1, A and C), at all time points it was less than 8% of alpha 1 mRNA. To test whether these findings were peculiar to bile duct ligation, which causes periportal injury (28), we carried out a similar study in rats treated for 1 week with dimethylnitrosamine. This chemical causes midzonal and pericentral necrosis (29). The profiles of alpha 1 and alpha 2 expression were entirely similar (Fig. 1, B and C).


Fig. 1. In vivo expression of alpha 1 and alpha 2 mRNA by hepatic stellate cells isolated from normal or injured livers. Hepatic stellate cells were isolated from normal livers or at different time points after bile duct ligation (BDL, 12 h, 48 h, and 6 (d) days) (A) or after dimethylnitrosamine treatment (1 (w) week (DMN)) (B), with three animals in each group. Total RNA was extracted and analyzed by RNase protection assay with specific probes for the alpha 1 and alpha 2 integrin subunits and for the ribosomal protein S14. The same RNA extract was used for all probes at individual time points. A and B, autoradiograms; arrows indicate specific bands. C, densitometry quantification of the autoradiogram presented in A and B showing the relative expression of alpha 1 and alpha 2 mRNA after correction for S14. Mean ± S.E. for each group (*p < 0.05 compared with normal). black-square, alpha 1 mRNA; square , alpha 2 mRNA.

[View Larger Version of this Image (27K GIF file)]


Surface Expression of alpha 1, alpha 2, and beta 1 by Stellate Cells

Expression at the protein level was assessed with specific antibodies to alpha 1, alpha 2, and beta 1 subunits on stellate cells freshly isolated as above. Bound antibody was quantitated by flow cytometry. To ensure that the integrin subunits of interest were not altered by the proteases used in cell isolation, we carried out control studies with WKY cells, a smooth muscle line that is known to express both alpha 1beta 1 and alpha 2beta 1 (4). Prior to analysis, WKY cells were exposed to Pronase and collagenase as for isolation of stellate cells and then washed and analyzed. All three subunits alpha 1, alpha 2, and beta 1 were detected (Fig. 2A). In normal stellate cells (Fig. 2B), alpha 1 and beta 1 were present but not alpha 2. At 12 h (Fig. 2C) and 6 days (Fig. 2D) after induction of injury, the findings were essentially the same: alpha 2 was not detectable despite the observed, albeit small, increase in alpha 2 mRNA at these time points (Fig. 1).


Fig. 2. Surface expression of alpha 1, alpha 2, and beta 1 integrin subunits by hepatic stellate cells in vivo. WKY cells, which express both alpha 1beta 1 and alpha 2beta 1, were exposed to Pronase and collagenase as for isolation of stellate cells and processed for flow cytometry after incubation with specific monoclonal antibodies to the extracellular domain of alpha 1, alpha 2, or beta 1 integrin. All three subunits were detected (A). Hepatic stellate cells were isolated from normal liver (B), at 12 h (C), or 6 days (D) after bile duct ligation (BDL). At all time points, only alpha 1 and beta 1 were detected.

[View Larger Version of this Image (39K GIF file)]


Immunofluorescence Detection of alpha 1 and alpha 2 in Liver Tissue during Injury

In immunohistology of normal liver, alpha 1 appeared as a sharp linear stain along the sinusoids consistent with its localization to stellate or endothelial cells. At 6 days after bile duct ligation, staining was unchanged. In neither setting was alpha 2 detectable, in agreement with the fluorescence-activated cell sorter analysis. The reactivity of the alpha 2 antibody in immunohistology was verified by positive staining of rat footpad skin (30) (data not shown).

Stellate Cell Binding to Collagen I and IV

Stellate cells were isolated 6 days after bile duct ligation, and their adhesion to collagen was tested. Antibody to alpha 1 integrin reduced adhesion to collagen type I by 90% and to collagen type IV by 95% (Fig. 3). Antibody to alpha 2 had no effect, and the combination of anti-alpha 1 and anti-alpha 2 had effects similar to those of anti-alpha 1 alone. Anti-beta 1 inhibited 55% of the binding to collagen type I and 80% of the binding to collagen type IV. Although the effect of anti-beta 1 was on average less than that of anti-alpha 1, the difference was not significant. Anti-alpha v had no effect on binding to either type of collagen. From these results, and studies at both the mRNA and the protein levels, we conclude that expression of alpha 2 integrin is negligible both in normal liver and in the setting of wound healing.


Fig. 3. Effect of blocking antibodies to alpha 1, alpha 2, and beta 1 integrin subunits on the binding of stellate cells to collagens I or IV. 96-Well plates were coated with 10 µg/ml collagen I (black-square) or IV (). Freshly isolated hepatic stellate cells were treated or not with the indicated antibodies for 15 min prior to plating. Coated wells received 100,000 cells. After incubation for 2 h, unattached cells were removed with washes. Bound cells were stained with crystal violet, and the absorbance was measured at 595 nm. All values have been corrected for background, estimated as cells adhering to wells coated with bovine serum albumin only. The effect of antibody is depicted as a percentage of the adhesion observed in the absence of antibody and represents mean ± S.E. of triplicate wells. At least three independent experiments were performed, of which a representative one is shown (*p < 0.05 versus adhesion in the absence of antibody).

[View Larger Version of this Image (16K GIF file)]


Role of alpha 1beta 1 and alpha 2beta 1 Integrins in Stellate Cell Contraction

For studies of contraction, stellate cells were isolated 6 days after bile duct ligation at which time they exhibit myofibroblast characteristics, attaching rapidly to collagen gels. Contraction was elicited by endothelin 1 (27, 31, 32), and the decrease in lattice area was monitored in the presence or absence of blocking antibodies to alpha 1, alpha 2, or beta 1 integrin subunits. Base-line contraction (indicated as 100% contraction) was established in plates treated with non-immune IgG and exposed to endothelin 1 (Fig. 4); the gel area was 40-50% that of non-contracted controls. Anti-alpha 1 blocked contraction significantly. Unexpectedly, the effect of anti-alpha 2 also was significant although less than that of anti-alpha 1. Given together, anti-alpha 1 and anti-alpha 2 were additive, completely inhibiting contraction, and anti-beta 1 was similarly effective. Antibody to alpha v, which does not bind collagen, had no effect. When the morphology of cultures on collagen gels was examined, the effect of an individual antibody on cell processes correlated closely with its effect on contraction. Processes were numerous in control cultures or in cultures exposed to anti-alpha v (Fig. 5, a and f). By contrast, in cultures exposed to anti-alpha 1 or anti-alpha 2 (Fig. 5, b and c), processes were reduced, and they were virtually eliminated in cultures containing both anti-alpha 1 and anti-alpha 2 or anti-beta 1 (Fig. 5, d and e). None of the antibodies altered cell attachment to the gel.


Fig. 4. Effect of blocking antibodies to alpha 1, alpha 2, and beta 1 integrin subunits on contraction of collagen gels by hepatic stellate cells. Hepatic stellate cells isolated from livers 6 days after bile duct ligation were plated on top of collagen I gels in the absence or presence of specific monoclonal antibodies as indicated. After 24 h, contraction was elicited by the addition of endothelin 1, and the change in lattice area was monitored; over 24 h endothelin reduced the diameter of the gel to 40-50% of parallel control cultures without the agonist. Contraction assays were done in triplicate, and at least three independent experiments were performed for each condition. A representative result is shown. The effect of blocking antibody is recorded as percent of maximal contraction ± S.E. (*p < 0.05 versus control with endothelin 1).

[View Larger Version of this Image (12K GIF file)]



Fig. 5. Effect of blocking antibody to alpha 1, alpha 2, or beta 1 integrin subunits on stellate cell morphology. Hepatic stellate cells isolated from livers 6 days after bile duct ligation were plated on top of collagen I gels in the absence or presence of specific monoclonal antibodies. After 24 h, the morphology of living cells was examined by phase-contrast microscopy. a, no antibody; b, anti-alpha 1; c, anti-alpha 2; d, anti-alpha 1 + anti-alpha 2; e, anti-beta 1; f, anti-alpha v. In the control and in cultures treated with anti-alpha v, numerous cell processes are present (arrows); these are reduced in the presence of either anti-alpha 1 or anti-alpha 2 and nearly abolished by the combination of anti-alpha 1 and anti-alpha 2 or by anti-beta 1.

[View Larger Version of this Image (138K GIF file)]


Regulation of alpha 2beta 1 Expression in Stellate Cells Cultured on Collagen Gels

A salient difference between these and the preceding experiments is the fact that the flow cytometry and collagen-binding studies were conducted with fresh isolates, whereas the contraction studies required a minimum period in culture (about 24 h) for attachment of the cells to the gel. Because phenotypic adaptation to culture is known to occur within this time frame (10, 11), we evaluated alpha 2 integrin mRNA expression early after cell plating. Cells from 6-day bile duct ligated liver were isolated and placed on collagen gels, and alpha 1 and alpha 2 mRNA were quantitated. As shown (Table I), alpha 2 mRNA increased strikingly after just 24 h of culture, and synthesis of its protein was readily detected by immunoprecipitation after metabolic labeling. By contrast, alpha 1 expression did not change either at the mRNA or protein level during 24 h of culture on collagen gels (Fig. 6). The rapid up-regulation of alpha 2beta 1 in culture appears to explain its participation in contraction.

Table I. Regulation of alpha 1 and alpha 2 mRNA expression by activated stellate cells in culture for 24 hours on collagen gels

Hepatic stellate cells were isolated from livers 6 days after bile-duct ligation. One-half of the harvest was taken for RNA extraction. The remaining cells were plated on top of collagen I gels and harvested after 24 hours in culture. RNase protection assay was used to quantify expression of the alpha 1 and alpha 2 integrin subunits and the ribosomal protein S14. Data are densitometric units after correction for the amount of S14 and represent the mean ± S.E. for each group (n = 7).

Densitometric units
Fold increase at 24 h
Fresh isolates 24-h culture

 alpha 1 mRNA 5982  ± 907 5255  ± 545 0.88
 alpha 2 mRNA 449  ± 61 3465  ± 1515a 7.71

a p < 0.05 compared to fresh isolates.


Fig. 6. Synthesis of alpha 1beta 1 and alpha 2beta 1 integrins by hepatic stellate cells in culture. Hepatic stellate cells in culture were labeled overnight with [35S]methionine, lysed as described under "Experimental Procedures" and immunoprecipitated with monoclonal antibody to alpha 1, alpha 2, or beta 1 integrins. Immunoprecipitates were resolved by SDS-polyacrylamide gel electrophoresis and autoradiography. Controls consisted of extracts processed in parallel with nonspecific antibody.

[View Larger Version of this Image (38K GIF file)]


Distribution of the alpha 1 or alpha 2 Integrin Subunits in Cultured Stellate Cells and Their Co-localization with the Actin Cytoskeleton

Double labeling experiments on 3-day cultured stellate cells revealed a striking difference in the distribution of alpha 1 and alpha 2 integrins (Fig. 7). alpha 1 was present on processes and at the periphery of cells to a much greater extent than was alpha 2; the latter was concentrated over and around the nucleus, suggestive of a largely cytoplasmic localization. Double labeling with anti-alpha 1 and anti-talin showed widespread co-localization of these proteins. By contrast, the association of alpha 2 and talin was most evident in the cell body. Although not absent in processes, it was clearly much less than that of alpha 1 and talin. The data confirm the up-regulation of the alpha 2 integrin subunit but suggest that the actin cytoskeleton in these early cultures forms peripheral complexes predominantly with alpha 1beta 1. The limited localization to peripheral processes provides a basis for the inhibitory effect, which is modest but significant, of anti-alpha 2 antibody on the contraction of stellate cells in culture.


Fig. 7. Distribution and co-localization of alpha 1beta 1, alpha 2beta 1, and talin in early primary cultured stellate cells. Hepatic stellate cells were cultured for 3 days and immunostained as described under "Experimental Procedures." Staining was examined with a confocal microscope (Meridian ACAS 570). Images have been corrected for compensation and threshold. No smoothing has been performed. First row, double labeling for alpha 2 (left), alpha 1 (middle), and overlay of the images (right); co-localization of the two antigens, indicated by yellow in the overlay image, is limited to the cell body (arrowhead indicates cell process). Second row, double labeling for talin (left), alpha 1 (middle), and overlay of the images (right); co-localization, indicated by yellow in the overlay, is extensive and includes cell processes (arrowhead). Third row, double labeling of alpha 2 (left), talin (middle), and overlay of the two (right); co-localization, indicated by yellow in the overlay image, is limited and similar to that of alpha 1 and alpha 2 (top row, right). Top row and third row: color scale, 0-1200; second row: full color scale.

[View Larger Version of this Image (60K GIF file)]



DISCUSSION

From studies with individual cell lines, it is clear that both alpha 1beta 1 and alpha 2beta 1 may exist on the same cell type and that either or both can provide the anchorage needed for contraction (3-7). On the other hand, expression of the respective integrins in the mature organism in vivo appears to be restricted by cell type with little overlap between the two. The separation appears to be maintained even in mutant mice lacking alpha 1, in which there is no evidence of a compensatory increase in alpha 2 expression (33). alpha 1 is expressed on smooth muscle, microvascular endothelium, glomerular mesangium, mammary myoepithelial cells, and chondrocytes (33). alpha 2 appears on fibroblasts, but its predominant distribution is to epithelium, particularly at sites of proliferation (15, 30). In normal human liver, it is reportedly on the biliary epithelium, although alpha 1 is present on hepatocytes and sinusoidal lining cells (34, 35). In the present study, alpha 1 mRNA was found on hepatic stellate cells, whereas alpha 2 was not detectable even with a sensitive RNase protection assay. After injury, alpha 2 mRNA was detectable although its protein was not, even on the biliary epithelium. The discrepancy with the alpha 2 data from human liver may be species-related or reflect a difference in the relative affinity of the anti-human and anti-murine antibodies.

To ensure that the finding of alpha 2 mRNA was not peculiar to the biliary ligation model, we performed a similar evaluation of injury induced by the toxin dimethylnitrosamine, with essentially identical results. Although the data confirm that liver myofibroblasts may co-express these integrins (36), the marked predominance of alpha 1beta 1 indicates that, of the two, it is functionally the most important. This conclusion is clearly supported by the binding studies, which indicate that essentially all stellate cell binding to collagen I or IV is mediated by alpha 1beta 1 (Fig. 4). The data differ from those of Schiro and colleagues (7), who evaluated the contractile function of a human fibroblast cell line and of transfected rhabdomyosarcoma cells, concluding that only alpha 2 is important. Although the cells reportedly expressed both alpha 1 and alpha 2 (7), the relative level of these integrins was not assessed nor was the binding activity of alpha 1 examined. It is known that a cell line expressing alpha 1 only is capable of contracting a collagen lattice (4). Thus, it appears that both integrins can subserve contraction and that the predominance of one or the other in a specific cell type or physiological circumstance will reflect its relative expression on the cell surface, apart from considerations of receptor activation and signaling pathways. Our data indicate that in vivo the expression of alpha 1 on myofibroblasts far exceeds that of alpha 2.

The role of alpha 1 and alpha 2 integrins in contraction of collagen gels by activated stellate cells was examined with direct experiments in vitro, in which cells were plated with or without the appropriate monoclonal blocking antibody. Neither anti-alpha 1 nor anti-alpha 2 (or both together) reduced cell attachment to the gels, indicating the presence of other receptor(s). The principal fibronectin receptor, alpha 5beta 1, is well expressed by stellate cells,2 and activated stellate cells produce significant fibronectin (21), which may add to a collagenous substratum through its well characterized collagen-binding domain (37, 38), thus providing a ligand for alpha 5beta 1. By a similar mechanism involving other secreted ECM proteins, a variety of receptors (integrins and others) could substitute for alpha 1beta 1, mediating the attachment of cells to collagen gels.

Although not altering attachment, the antibodies to alpha 1 and alpha 2 nonetheless had well-defined effects on morphology, causing retraction of cell processes. Qualitatively, such effects closely paralleled the ability of these same antibodies to inhibit contraction. The morphological change suggests that both integrins occupy the periphery and cell processes, as would be expected for attachments that provide traction. Confocal microscopy confirms that this is the case for alpha 1. The localization of alpha 2 differed in being more central than peripheral, although the limited expression on cell processes still may be sufficient to account for the small but significant effect of anti-alpha 2 on stellate cell contraction. If the change in alpha 2 expression is persistent, as seems likely, the data provide an explanation for the fact that alpha 2 integrin commonly is present on smooth muscle cell lines despite its absence on this cell type in vivo (15, 30). This has implications not only for the use of myofibroblast lines in modeling contraction but also for primary culture. Several studies point to the fact that normal stellate cells respond to culture with a program of gene expression that mimics activation in vivo (10). The up-regulation of alpha 2beta 1 in early primary cells, while demonstrating the latent capacity for expression of this integrin, indicates that the culture model deviates significantly from in vivo reality, highlighting the necessity for routinely validating with intact tissue the findings from culture models.

The relatively constant expression of alpha 1beta 1 in normal liver and during wound healing is at variance with data from other tissues in which this integrin increases with injury and fluctuates during development, as judged by immunohistology (39, 40). For example, it is undetectable in the normal rat carotid but clearly present in the neointima after balloon injury (33), suggesting that its level and timing may be critical to contraction. In this respect, the injury response of epithelia may differ from that of the vasculature.

The findings suggest that in liver the level of alpha 1 expression does not govern the contractile response. If not alpha 1, then what? The principal contractile agonists for activated stellate cells are endothelins 1 and 3. Interestingly, expression of their receptors is prominent on normal stellate cells and, like alpha 1 integrin, unaffected by injury (41). Expression of endothelin 1 by stellate cells, however, is up-regulated in injury (41, 42). If regulation of contraction by endothelin is autocrine, then this is significant. Another potentially regulatory factor is the ECM. Although collagen IV is a ligand for alpha 1beta 1 and is found normally in the subendothelial space, contraction may require organized fibrillar collagens, which are sparse in normal liver. Collagen I is confined largely to vascular branch points where it may serve as a substratum for vasoregulatory stellate cells (43). Similarly, contraction in hepatic wound healing may require deposition of the appropriate substratum in the form of fibrillar collagen (types I, III, V, and VI) at the injury site. A final variable is the rate at which stellate cells in the injured liver acquire the necessary contractile apparatus, which must be synthesized de novo; this process is mirrored by expression of smooth muscle alpha -actin (8, 9, 11), which increases in parallel with contractility (44).

In summary, contraction of hepatic myofibroblasts in wound healing utilizes the alpha 1beta 1 integrin. We find no evidence for a role of alpha 2beta 1. Because alpha 1beta 1 is expressed quasi-constitutively, contractility may depend primarily on formation of a fibrillar ECM at the injury site, coupled with cellular expression of contractile proteins and local (autocrine) elaboration of the appropriate agonist in the form of endothelins 1 and 3. Given that these events are co-temporal, the possibility exists that they are coordinated by signaling via alpha 1beta 1. This is a topic for further studies.


FOOTNOTES

*   This work was supported by the French Association for the Study of Liver, the French Association for Research on Cancer, the American Liver Foundation (L. R.-S.), and by Grants DK 31198, DK 26743, DK 50574, and DK 02124 from the National Institutes of Health.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    To whom correspondence should be addressed: Gastrointestinal Unit, Box 0538, University of California, San Francisco, CA. Tel.: 415-476-5072; Fax: 415-476-0659; E-mail: dmbiss{at}itsa.ucsf.edu.
1   The abbreviations used are: ECM, extracellular matrix; PBS, phosphate-buffered saline.
2   S. S. Wang and D. M. Bissell, unpublished observations.

ACKNOWLEDGEMENTS

We thank Victor Koteliansky, Philip Gotwals, and Biogen Inc. (Boston, MA) for antibodies to alpha 1, alpha 2, and beta 1 and for helpful discussions. We thank Samuel Santoro for generously providing cDNA and antibody to alpha 2 and advice on its use in immunohistochemistry, and we thank Guido Tarone (Torino, Italy) for antibody to alpha 1 and alpha 2. Bill Hyun provided valuable assistance with confocal microscopy through the Microscopy Core Facility of the UCSF Liver Core Center. L. R.-S. thanks Shao-Shean Wang for precious time spent in teaching techniques and David Tyler for stellate cell isolations.


REFERENCES

  1. Skalli, O., and Gabbiani, G. (1988) in The Molecular and Cellular Biology of Wound Repair (Clark, R. A. F., and Henson, P. M., eds), pp. 373-402, Plenum Publishing Corp., New York
  2. Irle, C., Kocher, O., and Gabbiani, G. (1980) J. Submicrosc. Cytol. 12, 209-217
  3. Carver, W., Molano, L., Reaves, T. A., Borg, T. K., and Terracio, L. (1995) J. Cell. Physiol. 165, 425-437 [CrossRef][Medline] [Order article via Infotrieve]
  4. Gotwals, P. J., Chi-Rosso, G., Lindner, V., Yang, J., Ling, L., Fawell, S. E., and Koteliansky, V. E. (1996) J. Clin. Invest. 97, 2469-2477 [Medline] [Order article via Infotrieve]
  5. Klein, C. E., Dressel, D., Steinmayer, T., Mauch, C., Eckes, B., Krieg, T., Bankert, R. B., and Weber, L. (1991) J. Cell Biol. 115, 1427-1436 [Abstract/Free Full Text]
  6. Lee, R. T., Berditchevski, F., Cheng, G. C., and Hemler, M. E. (1995) Circ. Res. 76, 209-214 [Abstract/Free Full Text]
  7. Schiro, J. A., Chan, B. M. C., Roswit, W. T., Kassner, P. D., Pentland, A. P., Hemler, M. E., Eisen, A. Z., and Kupper, T. S. (1991) Cell 67, 403-410 [CrossRef][Medline] [Order article via Infotrieve]
  8. Ballardini, G., Fallini, M., Biagini, G., Bianchi, F. B., and Pisi, E. (1988) Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 56, 45-49 [Medline] [Order article via Infotrieve]
  9. Rockey, D. C., Boyles, J. K., Gabbiani, G., and Friedman, S. (1992) J. Submicrosc. Cytol. Pathol. 24, 193-203 [Medline] [Order article via Infotrieve]
  10. Friedman, S. L. (1993) N. Engl. J. Med. 328, 1828-1835 [Free Full Text]
  11. Bissell, D. M., and Guzelian, P. S. (1980) Ann. N. Y. Acad. Sci. 349, 85-97 [Medline] [Order article via Infotrieve]
  12. Mendrick, D. L., and Kelly, D. M. (1993) Lab. Invest. 69, 690-702 [Medline] [Order article via Infotrieve]
  13. Mendrick, D. L., Kelly, D. M., DuMont, S. S., and Sandstrom, D. J. (1995) Lab. Invest. 72, 367-375 [Medline] [Order article via Infotrieve]
  14. Turner, D. C., Flier, L. A., and Carbonetto, S. (1989) J. Neurosci. 9, 3287-3296 [Abstract]
  15. Wu, J. E., and Santoro, S. A. (1994) Dev. Dyn. 199, 292-314 [Medline] [Order article via Infotrieve]
  16. Wu, J. E., and Santoro, S. A. (1996) Dev. Dyn. 206, 169-181 [CrossRef][Medline] [Order article via Infotrieve]
  17. Ignatius, M. J., Large, T. H., Houde, M., Tawil, J. W., Barton, A., Esch, F., Carbonetto, S., and Reichardt, L. F. (1990) J. Cell Biol. 111, 709-720 [Abstract/Free Full Text]
  18. Bienkowski, R. S., Cowan, M. J., McDonald, J. A., and Crystal, R. G. (1978) J. Biol. Chem. 253, 4356-4363 [Free Full Text]
  19. Maher, J. J., and McGuire, R. F. (1990) J. Clin. Invest. 86, 1641-1648
  20. Ala-Kokko, L., Pihlajaniemi, T., Myers, J. C., Kivirikko, K. I., and Savolainen, E.-R. (1987) Biochem. J. 244, 75-79 [Medline] [Order article via Infotrieve]
  21. Jarnagin, W. R., Rockey, D. C., Koteliansky, V. E., Wang, S.-S., and Bissell, D. M. (1994) J. Cell Biol. 127, 2037-2048 [Abstract/Free Full Text]
  22. Friedman, S. L., and Roll, F. J. (1987) Anal. Biochem. 161, 1233-1247
  23. Irving, M. G., Roll, F. J., Huang, S., and Bissell, D. M. (1984) Gastroenterology 87, 1233-1247 [Medline] [Order article via Infotrieve]
  24. Chomczynski, P. (1993) BioTechniques 15, 532-537 [Medline] [Order article via Infotrieve]
  25. Rhoads, D. D., Dixit, A., and Roufa, D. J. (1986) Mol. Cell. Biol. 6, 2774-2783 [Abstract/Free Full Text]
  26. Weinacker, A., Chen, A., Agrez, M., Cone, R. I., Nishimura, S., Wayner, E., Pytela, R., and Sheppard, D. (1994) J. Biol. Chem. 269, 6940-6948 [Abstract/Free Full Text]
  27. Rockey, D. C., Housset, C. N., and Friedman, S. L. (1993) J. Clin. Invest. 92, 1795-1804
  28. Kountouras, J., Billing, B. H., and Scheuer, P. J. (1984) Br. J. Exp. Pathol. 65, 305-311 [Medline] [Order article via Infotrieve]
  29. Tsukamoto, H., Matsuoka, M., and French, S. W. (1990) Semin. Liver Dis. 10, 56-65 [Medline] [Order article via Infotrieve]
  30. Zutter, M. M., and Santoro, S. A. (1990) Am. J. Pathol. 137, 113-120 [Abstract]
  31. Kawada, N., Klein, H., and Decker, K. (1992) Biochem. J. 285, 367-371
  32. Pinzani, M., Failli, P., Ruocco, C., Casini, A., Milani, S., Baldi, E., Giotti, A., and Gentilini, P. (1992) J. Clin. Invest. 90, 642-646
  33. Gardner, H., Kreidberg, J., Koteliansky, V., and Jaenisch, R. (1996) Dev. Biol. 175, 301-313 [CrossRef][Medline] [Order article via Infotrieve]
  34. Couvelard, A., Scoazec, J.-Y., and Feldmann, G. (1993) Am. J. Pathol. 143, 738-752 [Abstract]
  35. Volpes, R., van den Oord, J. J., and Desmet, V. J. (1993) Am. J. Pathol. 142, 1483-1492 [Abstract]
  36. Carloni, V., Romanelli, R. G., Pinzani, M., Laffi, G., and Gentilini, P. (1996) Gastroenterology 110, 1127-1136 [CrossRef][Medline] [Order article via Infotrieve]
  37. Ingham, K. C., Brew, S. A., and Migliorini, M. M. (1989) J. Biol. Chem. 264, 16977-16980 [Abstract/Free Full Text]
  38. Owens, R. J., and Baralle, F. E. (1986) EMBO J. 5, 2825-2830 [Medline] [Order article via Infotrieve]
  39. Belkin, V. M., Belkin, A. M., and Koteliansky, V. E. (1990) J. Cell Biol. 111, 2159-2167 [Abstract/Free Full Text]
  40. Glukhova, M., Koteliansky, V., Fondacci, C., Marotte, F., and Rappaport, L. (1993) Dev. Biol. 157, 437-447 [CrossRef][Medline] [Order article via Infotrieve]
  41. Housset, C., Rockey, D. C., and Bissell, D. M. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 9266-9270 [Abstract/Free Full Text]
  42. Pinzani, M., Milani, S., Franco, R. D., Grappone, C., Caligiuri, A., Gentilini, A., Toshi-Guerra, C., Maggi, M., Failli, P., Ruocco, C., and Gentilini, P. (1996) Gastroenterology 110, 534-548 [CrossRef][Medline] [Order article via Infotrieve]
  43. Zhang, J. X., Pegoli, W. J., and Clemens, M. G. (1994) Am. J. Physiol. 266, G624-G632 [Abstract/Free Full Text]
  44. Rockey, D. C., and Weisiger, R. A. (1996) Hepatology 24, 233-240 [CrossRef][Medline] [Order article via Infotrieve]

Volume 272, Number 49, Issue of December 5, 1997 pp. 30911-30917
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Physiol. Rev.Home page
S. L. Friedman
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Physiol Rev, January 1, 2008; 88(1): 125 - 172.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. Qi, L. Chi, J. Faber, B. Koller, and A. J. Banes
ATP reduces gel compaction in osteoblast-populated collagen gels
J Appl Physiol, March 1, 2007; 102(3): 1152 - 1160.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
L. Yang, C.-C. Chan, O.-S. Kwon, S. Liu, J. McGhee, S. A. Stimpson, L. Z. Chen, W. W. Harrington, W. T. Symonds, and D. C. Rockey
Regulation of peroxisome proliferator-activated receptor-{gamma} in liver fibrosis
Am J Physiol Gastrointest Liver Physiol, November 1, 2006; 291(5): G902 - G911.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
N Uyama, L Zhao, E Van Rossen, Y Hirako, H Reynaert, D H Adams, Z Xue, Z Li, R Robson, M Pekny, et al.
Hepatic stellate cells express synemin, a protein bridging intermediate filaments to focal adhesions
Gut, September 1, 2006; 55(9): 1276 - 1289.
[Abstract] [Full Text] [PDF]


Home page
J R Soc InterfaceHome page
I. V Yannas
Similarities and differences between induced organ regeneration in adults and early foetal regeneration
J R Soc Interface, December 22, 2005; 2(5): 403 - 417.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. P. Ng, B. Hinz, and M. A. Swartz
Interstitial fluid flow induces myofibroblast differentiation and collagen alignment in vitro
J. Cell Sci., October 15, 2005; 118(20): 4731 - 4739.
[Abstract] [Full Text] [PDF]


Home page
JDRHome page
H.E. van Beurden, J.W. Von den Hoff, R. Torensma, J.C. Maltha, and A.M. Kuijpers-Jagtman
Myofibroblasts in Palatal Wound Healing: Prospects for the Reduction of Wound Contraction after Cleft Palate Repair
Journal of Dental Research, October 1, 2005; 84(10): 871 - 880.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Kikuchi, C. T. Griffin, S.-S. Wang, and D. M. Bissell
Role of CD44 in Epithelial Wound Repair: MIGRATION OF RAT HEPATIC STELLATE CELLS UTILIZES HYALURONIC ACID AND CD44v6
J. Biol. Chem., April 15, 2005; 280(15): 15398 - 15404.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Jokinen, E. Dadu, P. Nykvist, J. Kapyla, D. J. White, J. Ivaska, P. Vehvilainen, H. Reunanen, H. Larjava, L. Hakkinen, et al.
Integrin-mediated Cell Adhesion to Type I Collagen Fibrils
J. Biol. Chem., July 23, 2004; 279(30): 31956 - 31963.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
C. V. Whiting, J. F. Tarlton, M. Bailey, C. L. Morgan, and P. W. Bland
Abnormal Mucosal Extracellular Matrix Deposition Is Associated with Increased TGF-{beta} Receptor-expressing Mesenchymal Cells in a Mouse Model of Colitis
J. Histochem. Cytochem., September 1, 2003; 51(9): 1177 - 1189.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C. Guidry, K. M. Bradley, and J. L. King
Tractional Force Generation by Human Muller Cells: Growth Factor Responsiveness and Integrin Receptor Involvement
Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1355 - 1363.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
Q. Yu, L. G. Que, and D. C. Rockey
Adenovirus-mediated gene transfer to nonparenchymal cells in normal and injured liver
Am J Physiol Gastrointest Liver Physiol, March 1, 2002; 282(3): G565 - G572.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Vossmeyer, W. Hofmann, K. Loster, W. Reutter, and K. Danker
Phospholipase Cgamma Binds alpha 1beta 1 Integrin and Modulates alpha 1beta 1 Integrin-specific Adhesion
J. Biol. Chem., February 8, 2002; 277(7): 4636 - 4643.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
B. Hinz, G. Celetta, J. J. Tomasek, G. Gabbiani, and C. Chaponnier
Alpha-Smooth Muscle Actin Expression Upregulates Fibroblast Contractile Activity
Mol. Biol. Cell, September 1, 2001; 12(9): 2730 - 2741.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Abe, S. C. Donnelly, T. Peng, R. Bucala, and C. N. Metz
Peripheral Blood Fibrocytes: Differentiation Pathway and Migration to Wound Sites
J. Immunol., June 15, 2001; 166(12): 7556 - 7562.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
C. Ramos, M. Montaño, J. García-Alvarez, V. Ruiz, B. D. Uhal, M. Selman, and A. Pardo
Fibroblasts from Idiopathic Pulmonary Fibrosis and Normal Lungs Differ in Growth Rate, Apoptosis, and Tissue Inhibitor of Metalloproteinases Expression
Am. J. Respir. Cell Mol. Biol., May 1, 2001; 24(5): 591 - 598.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
J. Varani, D. Spearman, P. Perone, S. E. G. Fligiel, S. C. Datta, Z. Q. Wang, Y. Shao, S. Kang, G. J. Fisher, and J. J. Voorhees
Inhibition of Type I Procollagen Synthesis by Damaged Collagen in Photoaged Skin and by Collagenase-Degraded Collagen in Vitro
Am. J. Pathol., March 1, 2001; 158(3): 931 - 942.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Nykvist, H. Tu, J. Ivaska, J. Kapyla, T. Pihlajaniemi, and J. Heino
Distinct Recognition of Collagen Subtypes by alpha 1beta 1 and alpha 2beta 1 Integrins. alpha 1beta 1 MEDIATES CELL ADHESION TO TYPE XIII COLLAGEN
J. Biol. Chem., March 10, 2000; 275(11): 8255 - 8261.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. George, S.-S. Wang, A.-M. Sevcsik, M. Sanicola, R. L. Cate, V. E. Koteliansky, and D. M. Bissell
Transforming Growth Factor-{beta} Initiates Wound Repair in Rat Liver through Induction of the EIIIA-Fibronectin Splice Isoform
Am. J. Pathol., January 1, 2000; 156(1): 115 - 124.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. George, D. Roulot, V. E. Koteliansky, and D. M. Bissell
In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: A potential new therapy for hepatic fibrosis
PNAS, October 26, 1999; 96(22): 12719 - 12724.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
J. Ivaska, H. Reunanen, J. Westermarck, L. Koivisto, V.-M. Kahari, and J. Heino
Integrin {alpha}2{beta}1 Mediates Isoform-specific Activation of p38 and Upregulation of Collagen Gene Transcription by a Mechanism Involving the {alpha}2 Cytoplasmic Tail
J. Cell Biol., October 18, 1999; 147(2): 401 - 416.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
D. K. Podolsky
V. Innate mechanisms of mucosal defense and repair: the best offense is a good defense
Am J Physiol Gastrointest Liver Physiol, September 1, 1999; 277(3): G495 - G499.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. M. Zutter, S. A. Santoro, J. E. Wu, T. Wakatsuki, S. K. Dickeson, and E. L. Elson
Collagen Receptor Control of Epithelial Morphogenesis and Cell Cycle Progression
Am. J. Pathol., September 1, 1999; 155(3): 927 - 940.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
D. W. Powell, R. C. Mifflin, J. D. Valentich, S. E. Crowe, J. I. Saada, and A. B. West
Myofibroblasts. I. Paracrine cells important in health and disease
Am J Physiol Cell Physiol, July 1, 1999; 277(1): C1 - C19.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. A. Klekotka, S. A. Santoro, and M. M. Zutter
alpha 2 Integrin Subunit Cytoplasmic Domain-dependent Cellular Migration Requires p38 MAPK
J. Biol. Chem., March 16, 2001; 276(12): 9503 - 9511.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Racine-Samson, L.
Right arrow Articles by Bissell, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Racine-Samson, L.
Right arrow Articles by Bissell, D. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement